Evidence map›Paper›PMID 21994361›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake.

Amanda M Dossat, Nicole Lilly, Kristen Kay, Diana L Williams

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 165 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
165citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

165 citing papers in PubMed, 1 synthesis or guideline pooled it, 246 citations in OpenAlex.

  1. Pooled it
  2. Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Review
  17. Review
  18. Article
  19. Review
  20. Article

105 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Amanda M DossatDepartment of Psychology and Program in Neuroscience, Florida State University, Tallahassee, Florida 32306-4301, USA.
Nicole Lilly
Kristen Kay
Diana L Williams
Florida State University · US

Funding

Brain integration of adiposity and satiety signals in the control of food intakeR00DK078779 · NIDDK · FLORIDA STATE UNIVERSITY · PI WILLIAMS, DIANA L · 2009 to 2011
$747k
Brain integration of adiposity and satiety signals in the control of food intakeK99DK078779 · NIDDK · UNIVERSITY OF WASHINGTON · PI WILLIAMS, DIANA L · 2007 to 2009
$212k
NIDDK NIH HHS DK078779NIDDK NIH HHS K99 DK078779NIDDK NIH HHS R00 DK078779
6 · The paper itself

Abstract

Central glucagon-like peptide 1 receptor (GLP-1R) stimulation suppresses food intake, and hindbrain GLP-1 neurons project to numerous feeding-relevant brain regions. One such region is the nucleus accumbens (NAc), which plays a role in reward and motivated behavior. Using immunohistochemical and retrograde tracing techniques in rats, we identified a robust projection from GLP-1 neurons in the nucleus of the solitary tract to the NAc. We hypothesized that activation of NAc GLP-1Rs suppresses feeding. When injected into the NAc core of rats at doses subthreshold for effect when administered to the lateral ventricle, GLP-1 significantly reduced food intake relative to vehicle at 1, 2, and 24 h posttreatment. The same doses had no effect when injected into the NAc shell. NAc core treatment with ventricle-subthreshold doses of the GLP-1R antagonist exendin (9-39) caused significant hyperphagia at 2 h posttreatment, suggesting that endogenous stimulation of NAc core GLP-1Rs plays a role in limiting food intake. It has been suggested that GLP-1 can cause nausea, but we found that NAc core administration of GLP-1 did not cause a conditioned taste aversion to saccharin, suggesting that the anorexic effect of NAc core GLP-1 is not caused by malaise. Finally, we observed that NAc core injection of GLP-1 significantly increased c-Fos expression in the NAc core. We conclude that that GLP-1Rs in the NAc play a physiologic role in food intake control, and suggest that the GLP-1 projection to NAc core may link satiation signal processing in the hindbrain with forebrain processing of food reward.

Indexed as

AnimalsAvoidance LearningConditioning, PsychologicalDose-Response Relationship, DrugEatingGene Expression RegulationGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorInjections, IntraventricularMaleNucleus AccumbensPeptide FragmentsProto-Oncogene Proteins c-fosRatsRats, WistarReceptors, Glucagon2-hydroxy-4,4'-diamidinostilbene, methanesulfonate saltexendin (9-39)Glp1r protein, ratGlucagon-Like Peptide 1Glucagon-Like Peptide-1 ReceptorPeptide FragmentsProto-Oncogene Proteins c-fosReceptors, GlucagonSaccharinStilbamidinesSweetening Agents

Identifiers

PMID21994361
PMCPMC3328130
OpenAlexW2117638217

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.